A study of QTc interval in healthy subjects with and without early repolarization

被引：0
|
作者：
Panicker, G. K. [1 ]
Manohar, D. [1 ]
Karnad, D. R. [1 ]
Salvi, V. [1 ]
Kothari, S. N. [1 ]
Lokhandwala, Y. Y. [1 ]
机构：
[1] Quintiles Cardiac Safety Serv, Mumbai, Maharashtra, India
来源：
EUROPEAN HEART JOURNAL | 2011年 / 32卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：927 / 927
页数：1
相关论文
共 50 条
  • [41] Levocetirizine does not prolong the QT/QTc interval in healthy subjects: results from a thorough QT study
    Hulhoven, Reginald
    Rosillon, Dominique
    Letiexhe, Michel
    Meeus, Marie-Anne
    Daoust, Agnes
    Stockis, Armel
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2007, 63 (11) : 1011 - 1017
  • [42] Absence of QTc prolongation with semaglutide: a thorough QT/QTc study in healthy subjects
    Demmel, V.
    Sandberg-Schaal, A.
    Jacobsen, J. B.
    Golor, G.
    Flint, A.
    Pettersson, J.
    EUROPEAN HEART JOURNAL, 2017, 38 : 1128 - 1129
  • [43] Lamotrigine does not prolong QTc in a thorough QT/QTc study in healthy subjects
    Dixon, Ruth
    Job, Sarah
    Oliver, Ruth
    Tompson, Debra
    Wright, John G.
    Maltby, Kay
    Lorch, Ulrike
    Taubel, Jorg
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2008, 66 (03) : 396 - 404
  • [44] The impact of posture on the cardiac depolarization and repolarization phases of the QT interval in healthy subjects
    Obata, Yurie
    Ruzankin, Pavel
    Ong, Qi Jia
    Berkowitz, Dan E.
    Berger, Ronald D.
    Steppan, Jochen
    Barodka, Viachaslau
    JOURNAL OF ELECTROCARDIOLOGY, 2017, 50 (05) : 640 - 645
  • [45] Evaluation of the Effect of Selumetinib on Cardiac Repolarization: A Randomized, Placebo- and Positive -controlled Crossover QT/QTc Study in Healthy Subjects
    Zhou, Diansong
    So, Karen
    Dymond, Angela W.
    Vik, Torbjorn
    Al-Huniti, Nidal
    Mariani, Gabriella
    Zorenyi, Gyorgy
    Huang, Yifan
    Holmes, Victoria
    Severin, Paul
    Rasmussen, Scott
    Martin, Paul
    CLINICAL THERAPEUTICS, 2016, 38 (12) : 2555 - 2566
  • [46] Effect of laquinimod, a novel immunomodulator in development for treatment of multiple sclerosis, on cardiac repolarization in healthy subjects: a thorough QT/QTc study
    Elgart, A.
    Mimrod, D.
    Rabinovich-Guilatt, L.
    Eyal, E.
    Morganroth, J.
    Spiegelstein, O.
    MULTIPLE SCLEROSIS JOURNAL, 2015, 21 : 318 - 319
  • [47] Lack of Effect of Rivipansel on QTc Interval in Healthy Adult African American Male Subjects
    Tammara, Brinda K.
    Plotka, Anna
    Shafer, Frank E.
    Readett, David R. J.
    Riley, Steve
    Korth-Bradley, Joan M.
    JOURNAL OF CLINICAL PHARMACOLOGY, 2017, 57 (10): : 1315 - 1321
  • [48] Randomized study of the effect of gadopiclenol, a new gadolinium-based contrast agent, on the QTc interval in healthy subjects
    Funck-Brentano, Christian
    Felices, Mathieu
    Le Fur, Nathalie
    Dubourdieu, Corinne
    Desche, Pierre
    Vanhoutte, Frederic
    Voiriot, Pascal
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2020, 86 (11) : 2174 - 2181
  • [49] Effect of Therapeutic and Supratherapeutic Doses of Vonoprazan on the QT/QTc Interval in a Phase I Randomized Study in Healthy Subjects
    Astruc, B.
    Jenkins, H.
    Jenkins, R.
    CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2017, 10 (03): : 208 - 216
  • [50] Evaluation of the effect on cardiac repolarization (QTc interval) of oncologic drugs
    Morganroth, J.
    APPROPRIATE DOSE SELECTION - HOW TO OPTIMIZE CLINICAL DRUG DEVELOPMENT, 2007, 59 : 171 - 184
12345